1 document found, page 1 of 1

Sort by Issue Date

How do hospital characteristics and ties relate to the uptake of second-generat...

Perelman, J; Duarte Ramos, F; Melo Gouveia, AM; Pinheiro, L; Ramos, F; Vogler, S; Mateus, C

Background There is limited evidence on within-country discrepancies in biosimilar uptake. This study analyzes differences in timing and diffusion of biosimilar uptake across Portuguese NHS hospitals and explores possible determinants. Research design and methods We analyzed publicly accessible consumption data of originator biologic and biosimilar drugs for adalimumab, etanercept, infliximab, rituximab, and tr...


1 Results

Queried text

Refine Results

Author








Date


Document Type


Access rights


Resource